Neogen

Brexit, FDA demands and other pressures hit Neogen’s top line

Michigan-based Neogen managed to chart 12% sales growth in Q1, but it's facing challenges ranging from an FDA-mandated withdrawal of a thyroid drug for dogs to currency woes caused by Brexit.

Arlene Weintraub Sep 28, 2016 9:28am

Neogen charts earnings turnaround on strong genomics sales

Jul 19, 2016 12:38pm

Neogen plunges on Q3 miss, CEO seeks growth for gene-testing

Mar 24, 2016 8:30am